Constitutively active Gsα is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 5, 1998, Pages 1624-1628

  Lania, Andrea ^a   Persani, Luca ^a   Ballaré, Emilia ^a   Mantovani, Simona ^a   Losa, Marco ^a   Spada, Anna ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; HUMAN GROWTH HORMONE; ISOBUTYLMETHYLXANTHINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE IV INHIBITOR; PROTEIN SUBUNIT;

ALPHA CHAIN; ARTICLE; CELL LEVEL; CLINICAL ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; FEEDBACK SYSTEM; FEMALE; GENE MUTATION; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-METHYL-3-ISOBUTYLXANTHINE; ADENOMA; ADULT; AGED; ENZYME INHIBITORS; FEMALE; GLYCOPROTEINS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; MUTATION; PITUITARY NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031754596     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.5.1624     Document Type: Article

References (28)

1. Spiegel AM. 1996 Mutations in G proteins and G protein coupled receptors in endocrine disease. J Clin Endocrinol Metab. 81:2434-2442.
2. Dumont JE, Jauniaux JC, Roger PP. 1989 The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci. 14:67-71.
3. Vallar L, Spada A, Giannattasio G. 1987 Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-568.
4. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. 1989 GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature. 340:692-696.
5. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemmoine NR. 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog. 4:345-349.
6. Spada A, Vallar L, Faglia G. 1992 G protein oncogenes in pituitary tumors. Trends Endocrinol Metab. 3:355-360.
7. Parma J, Duprez L, Van Sande J, et al. 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 365:652-654.
8. Parma J, Duprez L, Van Sande J, et al. 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsa genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab. 82:2695-2701.
9. Conti M, Jin CSL, Monaco L, Repaske DR, Swinnen JV. 1991 Hormonal regulation of cyclic nucleotide phosphodiesterase. Endocr Rev. 12:218-234.
10. Conti M, Nemoz G, Sette C, Vicini E. 1995 Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocr Rev. 16:370-389.
11. Swinnen JV, Tsikalas KE, Conti M. 1991 Properties and hormonal regulation of two structurally related phosphodiesterases from the rat Sertoli cell. J Biol Chem. 266:18370-18377.
12. Sette C, Iona S, Conti M. 1994 The short term activation of a rolipram-sensitive, cAMP specific phosphodiesterase by thyroid stimulating hormone in thyroid FRTL-5 cells is mediated by a cAMP-dependent phosphorylation. J Biol Chem. 269:9245-9252.
13. Nemoz G, Sette C, Hess M, Muca C, Vallar L, Conti M. 1995 Activation of cyclic nucleotide phosphodiesterase in FRTL-5 thyroid colls expressing a constitutively active Gsα. Mol Endocrinol. 9:1279-1287.
14. Spada A, Arosio M, Bochicchio D, et al. 1990 Clinical, biochemical and morphological correlates in patients bearing growth hormone-secreting pituitary rumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab. 71:1421-1426.
15. Landis C, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR. 1990 Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab. 71:1416-1420.
16. Adams EF, Brockmeier S, Friedmann E, Roth M, Buchfelder M, Fahlbusch R. 1993 Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery. 33:198-203.
17. Yang I, Park S, Ryu M, et al. 1996 Characteristics of gsp positive growth hormone secreting pituitary tumors in Korean acromeglic patients. Eur J Endocrinol. 134:720-726.
18. Billestrup N, Swanson LW, Vale W. 1986 Growth hormone releasing factor stimulates cell proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA. 83:6854-6857.
19. Bassetti M, Spada A, Arosio M, Vallar L, Brina M, Giannattasio G. 1986 Morphological studies on mixed growth hormone (GH) and prolactin (PRL)-secreting adenomas. Coexistence of GH and PRL in the same secretory granules. J Clin Endocrinol Metab. 418:405-410.
20. Chomczynski P. 1993 A reagent for single step simultaneous isolation of RNA, DNA e protein from cell and tissues samples. Biotecniques. 15:535-537.
21. Pandiella A, Reza-Elahi F, Vallar L, Spada A. 1988 Alfa 1-adrenergic stimulation of in vitro growth hormone release and cytosolic free Ca2+ in rat somatotrophs. Endocrinology. 122:1419-1425.
22. Lania A, Gil-del-Alamo P, Saccomanno K, Persani L, Faglia G, Spada A. 1995 Mechanism of action of pituitary adenylate cyclase-activating polypeptide (PACAP) in human nonfunctioning pituitary tumors. J Neuroendocrinol. 7:695-702.
23. Thompson WJ, Appleman MM. 1971 Multiple cyclic nucleotide phosphodiesterase activities in rat brain. Biochemistry. 10:311-316.
24. Koch B, Lutz-Bucher B. 1989 Indirect relationship between vasopressin induced secretion of ACTH and cyclic nucleotides in cultured rat pituitary cells. Eur J Pharmacol. 159:53-56.
25. LobbanM, Shakur Y, Beattie J, Houslay MD. 1994 Identification of two splice variant forms of type-IVB cyclic AMP phosphodiesterase, DPD (rPDE-IVB) and PDE-4 (rPDE-IVb) in brain: selective localization in membrane and cytosolic compartments and differential expression in various brain regions. Biochem J. 304:399-406.
26. Zachary I, Masters SB, Bourne HR. 1990 Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active Gs alpha. Biochem Biophys Res Commun. 168:1184-1193.
27. Ham J, Ivan M, Wynford-Thomas D, Scanlon MF. 1997 GH3 expressing constitutively active Gs alpha (Q227L) show enhanced hormone secretion and proliferation. Mol Cell Endocrinol. 127:41-47.
28. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. 1991 Activating mutations of the stimulatory G protein in the McCune Albright syndrome. N Engl J Med. 325:1688-1695.